| Literature DB >> 32160395 |
Guangcai Xu1, Michele Crotti1, Thangavelu Saravanan1,2, Kim M Kataja1, Gerrit J Poelarends1.
Abstract
Peroxygenases are heme-dependent enzymes that use peroxide-borne oxygen to catalyze a wide range of oxyfunctionalization reactions. Herein, we report the engineering of an unusual cofactor-independent peroxygenase based on a promiscuous tautomerase that accepts different hydroperoxides (t-BuOOH and H2 O2 ) to accomplish enantiocomplementary epoxidations of various α,β-unsaturated aldehydes (citral and substituted cinnamaldehydes), providing access to both enantiomers of the corresponding α,β-epoxy-aldehydes. High conversions (up to 98 %), high enantioselectivity (up to 98 % ee), and good product yields (50-80 %) were achieved. The reactions likely proceed via a reactive enzyme-bound iminium ion intermediate, allowing tweaking of the enzyme's activity and selectivity by protein engineering. Our results underscore the potential of catalytic promiscuity for the engineering of new cofactor-independent oxidative enzymes.Entities:
Keywords: enzyme engineering; epoxidation; oxidative enzymes; peroxide; peroxygenase
Mesh:
Substances:
Year: 2020 PMID: 32160395 PMCID: PMC7317984 DOI: 10.1002/anie.202001373
Source DB: PubMed Journal: Angew Chem Int Ed Engl ISSN: 1433-7851 Impact factor: 15.336
Figure 1Peroxygenase activity of 4‐OT variants. A) Reaction scheme of 4‐OT‐catalyzed epoxidation of 2 a using t‐BuOOH as oxidant. B) Comparison of the peroxygenase activity of wild‐type 4‐OT (WT) and engineered 4‐OT variants. C) Reaction progress curves using different 4‐OT variants. The initial rate of the 4‐OT(YIA)‐catalyzed reaction corresponds to 16 μm min−1; specific activity is 48 mU per mg of protein.
Figure 2Substrate scope of the epoxidation reactions catalyzed by 4‐OT(YIA) (Q4Y/M45I/F50A) using t‐BuOOH or H2O2 as the oxidant. Reaction conditions: 2 (1 mm), t‐BuOOH (100 mm) or H2O2 (25 mm), 4‐OT(YIA) (0.1 mg mL−1), NaPi buffer (20 mm), 5 % (v/v) EtOH (MeCN for 2 f, 2 g and 2 h). Conversions were calculated based on the depletion of the absorbance corresponding to substrate 2. Product identifications were performed by GC‐MS analysis. The enzymatic α,β‐epoxy‐aldehyde products 3 were reduced to the corresponding α,β‐epoxy‐alcohols with NaBH4 for chiral HPLC analysis. The e.r., d.r. and absolute stereochemistry of products were determined by chiral HPLC using authentic standards. The diastereomer ratio (d.r.) is defined as the syn/anti ratio. 2 j: E/Z=3:2; n.d.: not determined.
Figure 3Enantiocomplementary epoxidation of 2 a catalyzed by 4‐OT(YIA) using t‐BuOOH or H2O2 as oxidant. The predominant enzymatic diastereomer has the syn configuration; the minor anti diastereomeric product presumably is formed by rotation of the C2‐C3 bond after addition of the peroxide, but before ring closure.
Preparative‐scale 4‐OT(YIA)‐catalyzed epoxidations of α,β‐unsaturated aldehydes using t‐BuOOH as oxidant.[a]
|
Entry |
|
R1 |
R2 |
|
Conv. (Yield[%])[b] |
e.r.[c] |
d.r.[d] |
Abs. config.[e] |
|---|---|---|---|---|---|---|---|---|
|
1[f] |
|
H |
Ph |
24 |
93 (52) |
98:2 |
92:8 |
2 |
|
2 |
|
H |
|
48 |
85 (55) |
93:7 |
68:32 |
2 |
|
3 |
|
H |
|
66 |
85 (68) |
94:6 |
85:15 |
2 |
|
4 |
|
H |
|
48 |
91 (62) |
97:3 |
89:11 |
2 |
|
5 |
|
H |
|
24 |
95 (50) |
96:4 |
83:17 |
2 |
|
6[f] |
|
H |
|
46 |
98 (80) |
98:2 |
92:8 |
2 |
|
7 |
|
H |
|
48 |
92 (64) |
97:3 |
89:11 |
2 |
|
8 |
|
H |
|
45 |
90 (61) |
97:3 |
80:20 |
2 |
|
9[g] |
|
Me |
(CH3)2CCHCH2CH2 |
96 |
79 (50) |
96:4 |
60:40 |
2 |
[a] General reaction conditions: 2 (20 mm), t‐BuOOH (100 mm), 4‐OT(YIA) (0.93 mg mL−1) in 20 mm NaPi (sodium phosphate, pH 7.3) buffer with 10 % (v/v) EtOH (MeCN for 2 f and 2 g), volume=10 mL (5 mL for 2 a, 40 mL for 2 f), enzymatic product 3 reduced with NaBH4 to 4 after completion of the reaction [b] Conversion determined by GC‐MS; yield of the diastereomer mixture. [c] syn diastereomer; determined by chiral HPLC. [d] syn/anti. [e] syn diastereomer; determined by comparison with authentic standards on chiral HPLC. [f] conc. 2 a=50 mm, conc. 2 f=5 mm, see supporting information for details. [g] 2 j: E/Z=3:2; 1.3 mg mL−1 4‐OT(YIA).